Intellipharmaceutics International Inc. (IPCIF)
OTCMKTS: IPCIF · Delayed Price · USD
0.0600
-0.0600 (-50.00%)
Apr 23, 2024, 3:41 PM EDT - Market open

IPCIF Cash Flow Statement

Millions USD. Fiscal year is Dec - Nov.
Year 2022202120202019201820172016201520142013 2012 - 1997
Net Income
-2.89-2.89-5.15-3.39-13.74-8.94-10.14-7.44-3.86-11.5
Upgrade
Depreciation & Amortization
0.210.210.260.420.610.520.390.380.380.4
Upgrade
Share-Based Compensation
00.010.070.2601.752.260.421.751.15
Upgrade
Other Operating Activities
1.31.292.352.820.620.561.242.860.013.02
Upgrade
Operating Cash Flow
-1.39-1.39-2.460.11-12.51-6.11-6.25-3.78-1.71-6.93
Upgrade
Capital Expenditures
00-0-0-0.1-1.82-0.52-0.43-0.77-0.12
Upgrade
Acquisitions
0.4800.030000000
Upgrade
Other Investing Activities
0.020.5-00.03------
Upgrade
Investing Cash Flow
0.50.50.030.03-0.1-1.82-0.52-0.43-0.77-0.12
Upgrade
Common Stock Issued
03.073.070.0319.646.5410.111.296.576.2
Upgrade
Other Financing Activities
0.2-2.87-0.040.07-2.29-0.86-0.950.44-0.611.13
Upgrade
Financing Cash Flow
0.20.23.030.117.355.689.161.735.967.33
Upgrade
Net Cash Flow
-0.69-0.690.570.144.74-2.252.39-2.483.470.26
Upgrade
Free Cash Flow
-1.39-1.39-2.470.11-12.61-7.93-6.77-4.21-2.48-7.05
Upgrade
Free Cash Flow Margin
-2112.07%-2112.07%-175.90%7.72%-736.26%-144.06%-301.31%-102.90%-28.32%-461.47%
Upgrade
Free Cash Flow Per Share
-0.04-0.05-0.100.01-2.65-2.56-2.54-1.77-1.08-3.58
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.